Predictive and prognostic biomarkers in cancer: towards the precision medicine era.
作者信息
Marletta Stefano, Rizzo Antonio, Spoto Graziana, Falzone Luca
机构信息
Division of Pathology, Humanitas Istituto Clinico Catanese, 95045 Catania, Italy.
Department of Diagnostics and Public Health, Section of Pathology, University of Verona, 37134 Verona, Italy.
出版信息
Explor Target Antitumor Ther. 2024 Nov 20;5(6):1321-1325. doi: 10.37349/etat.2024.00278. eCollection 2024.
Abstract
摘要
相似文献
1
Predictive and prognostic biomarkers in cancer: towards the precision medicine era.
Explor Target Antitumor Ther. 2024 Nov 20;5(6):1321-1325. doi: 10.37349/etat.2024.00278. eCollection 2024.
2
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine.
Ann Oncol. 2021 Feb;32(2):183-196. doi: 10.1016/j.annonc.2020.11.013. Epub 2020 Nov 26.
3
Incorporating covariates information in adaptive clinical trials for precision medicine.
Pharm Stat. 2022 Jan;21(1):176-195. doi: 10.1002/pst.2160. Epub 2021 Aug 9.
4
Towards Circulating-Tumor DNA-Based Precision Medicine.
J Clin Med. 2019 Sep 2;8(9):1365. doi: 10.3390/jcm8091365.
5
Molecular Characterization of Prostate Cancers in the Precision Medicine Era.
Cancers (Basel). 2021 Sep 24;13(19):4771. doi: 10.3390/cancers13194771.
6
[Molecular biomarkers and prognostic factors for prostate cancer].
Urologe A. 2017 Jul;56(7):933-944. doi: 10.1007/s00120-017-0418-0.
7
Optimized biomarker evaluation and molecular testing in the era of breast cancer precision medicine.
Biotech Histochem. 2024 Oct;99(7):357-369. doi: 10.1080/10520295.2024.2390179. Epub 2024 Sep 11.
8
Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools.
PeerJ. 2021 May 7;9:e11412. doi: 10.7717/peerj.11412. eCollection 2021.
9
Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer.
Int J Mol Sci. 2023 Apr 20;24(8):7577. doi: 10.3390/ijms24087577.
10
A narrative review of prognostic indices in the evaluation of gastrointestinal cancers.
J Gastrointest Oncol. 2023 Aug 31;14(4):1849-1855. doi: 10.21037/jgo-23-159. Epub 2023 Jul 5.
引用本文的文献
1
The multifaceted role of microRNAs in colorectal cancer: pathogenesis and therapeutic implications.
Noncoding RNA Res. 2025 May 23;14:65-95. doi: 10.1016/j.ncrna.2025.05.012. eCollection 2025 Oct.
2
Biomarker-Driven Approaches to Bone Metastases: From Molecular Mechanisms to Clinical Applications.
Biomedicines. 2025 May 10;13(5):1160. doi: 10.3390/biomedicines13051160.
3
Diagnostic and Prognostic Significance of a Four-miRNA Signature in Colorectal Cancer.
Int J Mol Sci. 2025 Jan 30;26(3):1219. doi: 10.3390/ijms26031219.
本文引用的文献
1
Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score Test from a US Societal Perspective.
Clinicoecon Outcomes Res. 2024 Jun 4;16:471-482. doi: 10.2147/CEOR.S449711. eCollection 2024.
2
microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review.
Noncoding RNA Res. 2024 Mar 31;9(3):831-852. doi: 10.1016/j.ncrna.2024.03.013. eCollection 2024 Sep.
3
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots.
Int J Mol Med. 2024 May;53(5). doi: 10.3892/ijmm.2024.5366. Epub 2024 Mar 15.
4
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies.
Crit Rev Oncol Hematol. 2024 Apr;196:104295. doi: 10.1016/j.critrevonc.2024.104295. Epub 2024 Feb 20.
5
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review.
Ann Oncol. 2024 Jan;35(1):29-65. doi: 10.1016/j.annonc.2023.10.125. Epub 2023 Oct 23.
6
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Breast Cancer Res. 2023 Oct 2;25(1):112. doi: 10.1186/s13058-023-01718-0.
7
The Impact of Liquid Biopsies Positive for Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients.
Diagnostics (Basel). 2023 Jul 12;13(14):2347. doi: 10.3390/diagnostics13142347.
8
Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review.
Int J Mol Sci. 2023 Apr 24;24(9):7781. doi: 10.3390/ijms24097781.
9
An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing.
Front Oncol. 2023 Mar 13;13:1002792. doi: 10.3389/fonc.2023.1002792. eCollection 2023.
10
Targeting HER2-positive breast cancer: advances and future directions.
Nat Rev Drug Discov. 2023 Feb;22(2):101-126. doi: 10.1038/s41573-022-00579-0. Epub 2022 Nov 7.
Zotero 插件